Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Victor Cassella who wrote (631)	11/8/1997 9:30:00 AM
From: Kip518	Read Replies (1) \| Respond to of 1605

To all: Did anyone see the ABC News report on Friday night about an experimental drug called VEGF? Accoring to the report VEGF is a new way of treating heart disease: genetically engineering NEW blood vessels to literally grow new arteries! It could make the pain and risk of some heart surgery irrelevant! Imagine bypassing bypass surgery! (ref: abcnews.com. According to the report, a presentation on VEGF will be at the AHA meeting. I think Jennings also said drug could be available in 3-5 months (sounds implausible given certification requirements, but if the drug is herbally based might be a short time to market). I know nothing more about this than what Jennings reported, but it sounds like it be big trouble for VASO. Does anyone on the thread know anything more about VEGF? Thanks, Ron

To: Victor Cassella who wrote (631)	11/8/1997 11:27:00 AM
From: Don Walster	Respond to of 1605

Thank you, Victor, for your encouraging response. I own 40,000 shares of Vasomedical at 1 3/4. I am going to have to wait for over a year, maybe a year and a half to take a profit, if there is one by then, or get eaten alive by taxes. Whatever I buy, I always, always, always, buy to hold. The traders who are in there for a fast buck, and the analysts, and brokers, who may have a conflict of inerest, often cause market fluctuations that don't sidetrack me from my goal. Short term activity of that kind is a risky random walk. With regard to a conflict of interest, it took me a long time to discover that my ex-brokers were often recommending stocks that their companies had already bought, which were part of their inventory, and that they wanted to sell me for a profit. By the time I got in, everyone else had made their move, the game was over, the band had left, and they were sweeping out the gym. I bought Vaso for only one reason. A non-invasive treatment for angina makes sense, especially when reputable major hospitals and doctors have already successfully tested it. Kindesr regards, Don Walster